ImageneBio (IMA) Prepaid Assets (2020 - 2025)
ImageneBio (IMA) posted Prepaid Assets of $4.9 million for Q4 2025, little changed sequentially from $4.9 million in Q3 2025, and up 1311.14% YoY from $350000.0 in Q4 2024.
ImageneBio (IMA) Prepaid Assets (2020 - 2025) Analysis & Trends
ImageneBio has reported Prepaid Assets for 6 years, with the latest figure at $4.9 million in Q4 2025.
- Quarterly Prepaid Assets rose 1311.14% year-over-year to $4.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.9 million (up 1311.14% YoY) and the FY2025 annual result came in at $4.9 million, up 1311.14% from the prior year.
- Prepaid Assets steadied at $4.9 million in Q4 2025 per IMA's latest filing, from $4.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.3 million in Q2 2022 and troughed at $350000.0 in Q4 2024.
- A 5-year average of $3.8 million and a median of $3.6 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 89.05% in 2024, then soared 1311.14% in 2025.
- Over 5 years, Prepaid Assets stood at $4.3 million in 2021, then declined by 28.75% to $3.1 million in 2022, then gained by 4.37% to $3.2 million in 2023, then tumbled by 89.05% to $350000.0 in 2024, then jumped by 1311.14% to $4.9 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $4.9 million, $4.9 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 3.37 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 350,000.00 |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.82 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Sep 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 3.62 Mn |
| Jun 30, 2022 | 6.34 Mn |
| Mar 31, 2022 | 3.68 Mn |
| Dec 31, 2021 | 4.30 Mn |
| Sep 30, 2021 | 5.97 Mn |
| Jun 30, 2021 | 4.71 Mn |
| Mar 31, 2021 | 2.22 Mn |